Crossmark

Osteopontin derived from hypoxia-induced M2 macrophages promotes osteosarcoma progression through modulation of EGR3/ISG15 signaling and RIG-I expression

Crossref DOI link: https://doi.org/10.1186/s12967-025-06936-y

Published Online: 2025-08-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xing, Chunyang

Hu, Wei

Zhao, Liyuan
License Information

Text and Data Mining valid from 2025-08-21

Version of Record valid from 2025-08-21
More Information

Article History

Received: 10 February 2025

Accepted: 21 July 2025

First Online: 21 August 2025

Declarations

:

: All mice experiments were approved by the Laboratory of Animal Experimental Ethical Inspection of Dr. Can Biotechnology (Zhejiang) Co., Ltd. (Approval No. DRK-20240914021).

: Not applicable.

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest, and all authors report no conflicts of interest in this work.

Document is current

Any future updates will be listed below